Healthvista India IPO Particulars & Guidance at Chanakyanipothi.com, India`s Oldest & the most Trusted Investment website for coming up IPO. Operational since 8th December 1999, this is the Only Investment website in India, which has successfully completed 23 Years.
Healthvista India IPO Guidance
Will update soon
Healthvista India IPO Grey Market updates
# For latest updates, Click
Healthvista India IPO Subscription Status
Will update once the IPO opens.
Healthvista India IPO Promoters
The company is a professionally managed company and doesnot have an identifiable promoter
Healthvista India IPO Particulars & Guidance: About the Company
Healthvista India is the leading out-of-hospital healthcare provider in India, based on revenue and highest market share of 21% of the organised out-of-hospital healthcare market in Fiscal 2021, as well as in terms of the number of cities covered as of December 31, 2021. Under its well established brand Portea, it provides a comprehensive range of out-of-hospital healthcare services, including primary care, geriatric (elderly) and palliative (end-of-life) care, intensive care unit (“ICU”) care, post-operative and post-hospitalization care, chronic care, mother and baby care and cancer care, all at home. It also distributes specialty pharmaceuticals and provide “point of care” medical equipment for sale and rental. As of March 31, 2022, it had established 40 offices across India, entered into agreements with 63 hospitals, 80 corporates, eight insurers and 11 insurance third party administrators (“TPAs”), to provide out-of-hospital healthcare services to their patients, employees and insured customers, respectively.
It also works with reputed hospital-associated physicians as well as independent physicians and other key industry opinion leaders to provide out-of-hospital healthcare support requirements of their patients. As of March 31, 2022, it had developed relationships with 3,058 clinicians and had established formal arrangements with over 14 key opinion leaders across India. As of March 31, 2022, it employed or engaged 3,123 healthcare personnel, including 362 full-time employees on its rolls and 2,761 personnel engaged through third party contract arrangements. Between its incorporation and March 31, 2022, it had served over 1,200,000 unique patients (including patients under government schemes) across India across a diverse range of age and medical conditions.
Market Opportunity
The healthcare industry in India has grown at a CAGR of 14.54% from US$ 99 billion in 2013 to US$ 257 billion in 2020, and is expected to grow at a CAGR of 20.5% from 2020 to reach US$ 870 billion by 2027. Approximately 60% of healthcare requirements in India can be met through out-of-hospital healthcare services. Various aspects of medical care, including consultation, diagnostics, monitoring
and treatment for chronic care, post-hospitalisation care, nursing, rehabilitation, home-based ICUs, cancer care, stroke rehabilitation and other neurological conditions, chronic kidney disorder, chemotherapy at home, palliative care and other non-urgent healthcare services are capable of being provided at home, resulting in cost effective treatment solutions including avoiding unnecessary medical costs, and offering greater convenience for patients who are able to receive quality medical care and treatment at home. (Source: F&S Report) In 2020, the Indian out-of-hospital healthcare market in India was US$ 5.1 billion. Of this, the organized market constituted 3.2% and it had a market share of 21% of the organized market.
The total market for out-of-hospital healthcare is expected to grow at a CAGR of 17.5% from US$ 6.03 billion in 2021 to US$ 15.87 billion in 2027, but a significantly higher CAGR of 32.3% is expected for the organized segment.
For more information, click www.portea.com
Objects of the IPO
The Company proposes to utilize the Net Proceeds from the Fresh Issue towards funding the following objects:
1. Funding the working capital requirements of its Material Subsidiary, namely Medybiz Pharma Private Limited
2. Re-payment/ pre-payment of certain indebtedness availed by the Company
3. Purchase of medical equipment
4. Marketing and brand building activities
5. Inorganic growth initiatives and general corporate purpose.
Healthvista India IPO Particulars & Guidance
Healthvista India IPO Details & Analysis | |
IPO opens on | ? ,2023 |
IPO closes on | ? ,2023 |
Issue Type | Book Built Issue IPO |
Issue Size | ? Sh /Rs ? Cr |
* Fresh Issue | ? Sh /Rs 200 Cr |
* Offer for Sale | 56,252,654 Shares /Rs ? Cr |
Face Value per share: | Rs. 1 |
Price Band | Rs. ? |
Retail Discount | Rs 0 per share |
Employee discount | Rs. 0 per share |
Retail Lot Size | ? Shares |
Listing will at | BSE, NSE |
Shares offered to | Shares | Rs. in Cr |
QIB (10 %) | – | – |
NII (30 %) | – | – |
RII (60 %) | – | – |
Employees | – | – |
Total Shares | – | – |
Retail portion will be oversubscribed by | ? Forms. | |
How much Shares to Apply? | Net of RII discount | |
Min Retail Application | – Sh | Rs. – |
Max Retail Application | – Sh | Rs. – |
Small HNI (Min) application | – Sh | Rs. – |
Small HNI (Max) application | – Sh | Rs. – |
Big HNI Application | – Sh | Rs. – |
Healthvista India IPO Tentative timetable | |
IPO opens on | ? 2023 |
IPO Closes on | ? 2023 |
IPO Allotment on | ? 2023 |
Unblocking of ASBA | ? 2023 |
Credit of Shares | ? 2023 |
Listing on | ? 2023 |
Registered Office of the Company | |
No.69/B, 1st Cross, 1st Stage, Domlur Layout, Bengaluru 560 071, Karnataka, India | |
Lead Managers SBI Capital Markets, IIFL Securities, JM Financial |
|
Registrar to IPO Link Intime India Private Limited |
Healthvista India IPO Financial & Analytical Ratios | ||||
Year | Total Income | Net Profit | EPS | RoNW |
Rs. in Cr | Rs.in Cr | Rs. | % | |
2019-20 | 162.06 | (48.01) | (7.63) | (7.37) |
2020-21 | 130.38 | (37.01) | (5.88) | (5.39) |
2021-22 (9M) | 119.11 | (34.86) | (4.87) | (190) |
Book Value of the Share on | 31.09.2022 | Rs.(0.88) | ||
Book Value of the Share | after the FPO | Rs.? | ||
Offer Price at Cap | Rs. ? |
Ratio Analysis | |
Upper Price /last EPS | ? |
Upper Price/Book Value Ratio | ? |
Upper Price/BV after IPO | ? |
Healthvista India IPO Particulars & Guidance
Peer Comparison
There are no identifiable listed peers of the Company.
# This is only coverage of News related to Grey Market. We do not deal in grey market premium, nor we recommend dealing in Grey Market. Investment decision based on Grey Market trends can be faulty.
>>Go to SME IPOs Section: Click
>>Get Good Staff or Job, Click: Staffavailable.com
>>Interested in Used Automobiles or vintage cars? Click: BigGaddi.com
>>Get solid Guidance on Mutual fund Investments, Click: ChanakyaMFGuidance.com
>>Study Stock Research Reports, Click: AnalysisLibrary.com
>>Interested in Crossword Puzzles? Click: Magajmari.com